查詢結果分析
來源資料
相關文獻
- 食道靜脈曲張出血案例與治療介紹
- 一位肝硬化併發食道靜脈曲張患者的護理經驗
- 門脈高壓藥物治療的現況及未來
- 食道靜脈曲張的處理
- Comparison Between Esophageal Variceal Pressure and Portal Pressure in HBsAg-Positive Cirrhotics: the Effects of Vasopressin
- Pulmonary Function Changes in Cirrhotic Patients
- 肝硬化症併食道靜脈曲張施行短路手術時脾臟切除與否其血球和免疫球蛋白的研究
- 肝硬化食道靜脈曲張破裂之處置
- 肝硬化病人食道靜脈曲張破裂之藥物預防
- 獨居老人因肝硬化引發個人因應能力失調之護理經驗
頁籤選單縮合
題名 | 食道靜脈曲張出血案例與治療介紹=Introduction of Esophagus Varicosity Hemorrhage Case and the Treatment |
---|---|
作者 | 蔡佩玲; 李佳靜; | 書刊名 | 藥學雜誌 |
卷期 | 26:4=105 2010.12[民99.12] |
頁次 | 頁63-68 |
分類號 | 415.515 |
關鍵詞 | 肝硬化; 食道靜脈曲張; 血管加壓素; Liver cirrhosis; Esophagus varices; Vasopressin; |
語文 | 中文(Chinese) |
中文摘要 | 約50-70%的肝硬化病人會發生食道靜脈曲張的併發症。初期預防:發現中重度的胃食道靜脈曲張時,可使用非選擇性的β阻斷劑,有禁忌的病患就須選擇門脈結紮手術;疑似出血的治療:使用血管加壓素 vasopressin類藥物有 vasopressin(Pitressin)、 terlipressin(Glypressin),體抑素 somatostatin類包括 octreotide(Sandostatin)、 somatostatin(Stilamin)。二期預防: 50%的病患會發生再出血的症狀,其後續治療方式可發現其再出血的機率以未治療的出血率最大,可合併使用非選擇性的β阻斷劑與 Nitrates而降低再出血率到 30%。 |
英文摘要 | Approximately 50-70% of liver cirrhosis patients would complicate the esophagus varicosity(Esophageal varices, EV). Primary prophylaxis: non-selective β-blockers are used for the moderate to serious esophageal varices. However, ligation of portal vein may be performed for the patients with contraindication to β-blockers. Suspected varices bleeding is treated with vasoactivators, which including vasopressin and somatostatin. Vasopressin analogues include vasopressin(Pitressin)and terlipressin(Glypressin); somatostatin analogues include octreotide(Sandostatin)and somatostatin(Stilamin). Secondary prophylaxis: 50% of the patients with esophageal varices would have rebleeding. Those untreated patients with esophageal varices had the highest rate of rebleeding. We could combine nonselective β-blockers and nitrates for further treatment to decrease the incidence of rebleeding to 30%. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。